NETRI develops technologies that accelerate fundamental and medical research by offering neurofluidic devices to the pharmaceutical companies, CROs and public researchers specialising in neurosciences and neurological disorders.
NETRI's unique expertise and patented technologies in microfluidic neuroengineering enable the design, manufacture and application of physiologically relevant organ-on-chip in vitro Neurofluidics™ devices. These compartmentalized devices allow the understanding of the structural and functional mechanisms of neurological disorders and the exploration at high throughput of modes of action of a compound on murine or human cellular networks.